• Go to:

36th Annual EAU Congress (virtual edition), 8-12 July 2021

Welcome to the EAU Patient Day 2021!

2020 was an exceptionally challenging year for all of us, transitioning into the new normal with our fair share of virtual meetings, face mask wearing and social distancing. The EAU successfully met these challenges; the EAU20 Virtual Congress was a huge success and opened up other possibilities when it comes to organising meetings in the future.

With the pandemic still raging across the world, EAU21 will also be converted from a physical congress in Milan to a virtual congress, from 8-12 July. The absence of a physical annual meeting has not prevented EAU Patient Information (EAU PI) from working tirelessly, and I am very pleased to announce the very first EAU Patient Day, which offers a daylong series of patient-related activities during EAU21

I look forward to virtually seeing you to share your knowledge, experiences and insights into treatment and quality-of-life issues.

Mr. Eamonn T. Rogers
EAU Patient Information Chairman

Patient Day

The 36th Annual EAU Congress (EAU21 Virtual Congress) will see the premiere of the EAU Patient Day. For the past three years, patient involvement in the annual congress was limited to a Patient Information Session. This is going to change!

The EAU Patient Day will take place on Friday 9 July from 11.30 until 19.00 hrs:

Patient Day full programme – Friday, 9 July 2021
Prostate Cancer Session Virtual Room 10 11:30 – 12:30
Bladder Cancer Session Virtual Room 9 12:30 – 13:30
Kidney Cancer Session Virtual Room 10 13:30 – 14:30
Life after Cancer Treatment Session Virtual Room 9 14:30 – 15:30
Functional Urology Session Virtual Room 10 15:30 – 16:30
Patient Poster Session Virtual Room 9 16:30 – 17:30
The Top-5 Best Patient Poster Awards Virtual Room 9 17:30 – 17:40
Roundtable ‘The Road to Successful Intervention’ Virtual Room 2 18:00 – 19:00

We have a series of exciting activities lined up. Here is a peek of what we have in store for you:

Patient Information Sessions

The EAU21 Virtual Congress will offer Patient Information sessions, bringing you the latest on quality-of-life issues, updates based on the 2021 EAU Guidelines and other topics of interest. All delegates with an interest in the patient perspective are welcome to join.

EAU Patient Advocacy Group Members such as the Association of Cancer Leagues (ECL), the European Cancer Patient Coalition (ECPC), Europa Uomo (EUomo), the Kidney Cancer Patient Coalition (IKCC) and the World Bladder Cancer Patient Coalition (WBCPC) were involved in the composition of the sessions. The detailed programmes of the Patient Information sessions on the following topics will be available soon:

  • Bladder Cancer
  • Kidney Cancer
  • Prostate Cancer
  • Life after cancer treatment
  • Functional Urology

Patient Poster Session

Over the past months, patient advocates from across the globe were encouraged to actively contribute to the annual EAU Congress by submitting a poster abstract. The Patient Poster Session offers patient advocates an opportunity to share knowledge and insights into treatment and quality-of-life issues.

Read more.

The Patient Poster Session is brought to you by the European Association of Urology (EAU) with programme development support from Pfizer. The editorial content of this page was written independently of the sponsor and is judged to be free of any conflict of interest.

ADT Educational Programme

The ADT Educational Programme helps prostate cancer patients manage the side effects of ADT through an interactive programme built around the book Androgen Deprivation Therapy: An essential guide for men with prostate cancer and their loved ones.

Read more.

We thank Astellas Pharma Europe and Bayer HealthCare Pharmaceuticals Inc. for an unrestricted educational grant to initiate the online ADT Educational Programme in Europe.

Roundtable ‘The Road to Successful Intervention’

The objective of the Roundtable is to discuss the shared responsibilities of both the healthcare provider and patient during a prostate cancer patient’s care pathway.

Do healthcare providers ask the right questions during intake? Do patients provide all the information the healthcare provider needs, such as a detailed medical history and anything that could be relevant to the decision-making process, as to what care pathway to take?

More information will follow soon.

This roundtable discussion has been funded by Ferring Pharmaceuticals. The programme of this online activity has been independently developed and approved by the EAU Patient Office.

Patient Information Advisory Board

The Patient Information (PI) Advisory Board consists of patient group representatives who are also members of the EAU Patient Advocacy Group.
This Board is responsible for developing the EAU Patient Day as well as the selection of Patient Poster Abstracts.

Antonella Cardone (European Cancer Patient Coalition)

Ernst-Günther Carl (Europa Uomo)

John Dowling (Europa Uomo)

Rachel Giles (International Kidney Cancer Coalition)

Lydia Makaroff (World Bladder Cancer Patient Coalition)

June Rogers (ERN eUROGEN Patient Advisory Group)

Serena Bartezatti (ERN eUROGEN-Rare urogenital tumours & Functional urogenital conditions-Interstitial Cystitis)

Wendy Yared (Association of European Cancer Leagues)

Mary Lynne Van Poelgeest (World Federation for Incontince and Pelvic Problems)